Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target

被引：2
|
作者：
Ma, Haodong [1 ]
Ren, Shengju [1 ]
Meng, Qingpeng [1 ]
Su, Boyuan [1 ]
Wang, Kun [1 ]
Liu, YiChen [1 ]
Wang, Junpeng [2 ]
Ding, Degang [2 ]
Li, Xin [1 ,3 ,4 ]
机构：
[1] Zhengzhou Univ, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou 450001, Henan, Peoples R China
[2] Zhengzhou Univ Peoples Hosp, Henan Prov Peoples Hosp, Dept Urol, Zhengzhou 450003, Henan, Peoples R China
[3] Zhengzhou Univ, Collaborat Innovat Ctr Henan Prov Canc Chemopreven, Zhengzhou 450001, Henan, Peoples R China
[4] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Henan, Peoples R China
来源：
ARCHIVES OF VIROLOGY | 2023年 / 168卷 / 08期
基金：
中国国家自然科学基金;
关键词：
Tim-3; COVID-19; Immune response; T-CELL EXHAUSTION; BLOCKADE; AUTOIMMUNE; RESPONSES; PD-1; EXPRESSION; APOPTOSIS; RESTORES;
D O I：
10.1007/s00705-023-05842-2
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
T cell immunoglobulin and mucin domain containing protein 3 (Tim-3), an immune checkpoint, is important for maintaining immune tolerance. There is increasing evidence that Tim-3 is aberrantly expressed in patients with COVID-19, indicating that it may play an important role in COVID-19. In this review, we discuss the altered expression and potential role of Tim-3 in COVID-19. The expression of Tim-3 and its soluble form (sTim-3) has been found to be upregulated in COVID-19 patients. The levels of Tim-3 on T cells and circulating sTim-3 have been shown to be associated with the severity of COVID-19, suggesting that this protein could be a potential biomarker of COVID-19. Moreover, this review also highlights the potential of Tim-3 as a therapeutic target of COVID-19.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target
    Haodong Ma
    Shengju Ren
    Qingpeng Meng
    Boyuan Su
    Kun Wang
    YiChen Liu
    Junpeng Wang
    Degang Ding
    Xin Li
    Archives of Virology, 2023, 168
  • [2] Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
    Anderson, Ana C.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (05) : 393 - 398
  • [3] TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients
    Modabber, Zahra
    Shahbazi, Mehdi
    Akbari, Roghayeh
    Bagherzadeh, Mojgan
    Firouzjahi, Alireza
    Mohammadnia-Afrouzi, Mousa
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1707 - 1715
  • [4] Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
    Rowlands, Marianna
    Segal, Florencia
    Hartl, Dominik
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] The role of TIM-3 in sepsis: a promising target for immunotherapy?
    Wang, Changli
    Liu, Jinhai
    Wu, Qi
    Wang, Zhi
    Hu, Baoji
    Bo, Lulong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] TIM-3 as a new therapeutic target in systemic lupus erythematosus
    Pan, Hai-Feng
    Zhang, Ning
    Li, Wen-Xian
    Tao, Jin-Hui
    Ye, Dong-Qing
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 395 - 398
  • [7] HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
    Chen, Ruochan
    Huang, Yan
    Quan, Jun
    Liu, Jiao
    Wang, Haichao
    Billiar, Timothy R.
    Lotze, Michael T.
    Zeh, Herbert J.
    Kang, Rui
    Tang, Daolin
    HELIYON, 2020, 6 (12)
  • [8] Analysis of Tim-3 as a therapeutic target in prostate cancer
    Piao, Yongrui
    Jin, Xuanshun
    TUMOR BIOLOGY, 2017, 39 (07) : 1 - 6
  • [9] TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells
    Kikushige, Yoshikane
    Miyamoto, Toshihiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 627 - 633
  • [10] The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
    Ganjalikhani Hakemi, Mazdak
    Jafarinia, Morteza
    Azizi, Mahdieh
    Rezaeepoor, Mahsa
    Isayev, Orkhan
    Bazhin, Alexandr V.
    FRONTIERS IN ONCOLOGY, 2020, 10
12345